MD4471C1 - Purtător de colagen răsucit - Google Patents

Purtător de colagen răsucit

Info

Publication number
MD4471C1
MD4471C1 MDA20130097A MD20130097A MD4471C1 MD 4471 C1 MD4471 C1 MD 4471C1 MD A20130097 A MDA20130097 A MD A20130097A MD 20130097 A MD20130097 A MD 20130097A MD 4471 C1 MD4471 C1 MD 4471C1
Authority
MD
Moldova
Prior art keywords
collagen carrier
collagen
elongated members
carrier
coiling
Prior art date
Application number
MDA20130097A
Other languages
English (en)
Russian (ru)
Other versions
MD4471B1 (ro
MD20130097A2 (ro
Inventor
Вольфганг Шёнхофер
Пернилле Дибендал Педерсен
Пол Бертэльсен
Хенрик Брендер
Ингрид Бланка
Хенрик Нойшефер Ларсен
Original Assignee
Takeda As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda As filed Critical Takeda As
Publication of MD20130097A2 publication Critical patent/MD20130097A2/ro
Publication of MD4471B1 publication Critical patent/MD4471B1/ro
Publication of MD4471C1 publication Critical patent/MD4471C1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Manufacturing & Machinery (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)

Abstract

Invenţia se referă la un procedeu de preparare a unui purtător de colagen răsucit şi comprimat, la utilizarea lui pentru prevenirea sau tratamentul leziunilor în timpul intervenţiilor chirurgicale minimal invazive.Procedeul de preparare constă în răsucirea unui purtător de colagen, format dintr-un strat de colagen şi un strat de acoperire ce cuprinde fibrinogen şi trombină, şi include următoarele etape succesive: se umectează cel puţin o parte a purtătorului de colagen menţionat; se răsuceşte purtătorul de colagen prin prinderea lui între o pereche de elemente de formă alungită şi rotirea perechii de elemente alungite în jurul unei axe paralele cu o extensie longitudinală a elementelor alungite pentru răsucirea purtătorului de colagen pe elemente, în timp ce purtătorul de colagen este susţinut de către un dispozitiv de suport; se usucă purtătorul de colagen răsucit până la atribuirea unei forme stabile a acestuia.
MDA20130097A 2011-05-24 2012-05-24 Purtător de colagen răsucit MD4471C1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11167379 2011-05-24
PCT/DK2012/050178 WO2012159635A1 (en) 2011-05-24 2012-05-24 Rolled collagen carrier

Publications (3)

Publication Number Publication Date
MD20130097A2 MD20130097A2 (ro) 2014-06-30
MD4471B1 MD4471B1 (ro) 2017-03-31
MD4471C1 true MD4471C1 (ro) 2017-10-31

Family

ID=44692373

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20130097A MD4471C1 (ro) 2011-05-24 2012-05-24 Purtător de colagen răsucit

Country Status (37)

Country Link
US (2) US9814686B2 (ro)
EP (2) EP2713972B9 (ro)
JP (1) JP6025824B2 (ro)
KR (1) KR101833035B1 (ro)
CN (1) CN103702645B (ro)
AP (1) AP2013007327A0 (ro)
AR (1) AR086557A1 (ro)
AU (1) AU2012261339B2 (ro)
BR (1) BR112013029709B1 (ro)
CA (1) CA2837117C (ro)
CL (1) CL2013003274A1 (ro)
CO (1) CO6862131A2 (ro)
CY (1) CY1119313T1 (ro)
DK (2) DK3243489T3 (ro)
EA (1) EA028878B1 (ro)
ES (2) ES2642151T3 (ro)
GE (1) GEP201706715B (ro)
HR (1) HRP20171424T1 (ro)
HU (1) HUE032689T4 (ro)
IL (1) IL229446A (ro)
LT (1) LT2713972T (ro)
MD (1) MD4471C1 (ro)
ME (1) ME02830B (ro)
MX (1) MX355925B (ro)
MY (1) MY185054A (ro)
PE (1) PE20141037A1 (ro)
PL (2) PL2713972T3 (ro)
PT (1) PT2713972T (ro)
RS (1) RS56367B1 (ro)
SA (1) SA112330549B1 (ro)
SI (1) SI2713972T1 (ro)
TN (1) TN2013000391A1 (ro)
TW (1) TWI552774B (ro)
UA (1) UA113959C2 (ro)
UY (1) UY34096A (ro)
WO (1) WO2012159635A1 (ro)
ZA (1) ZA201307060B (ro)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3243489T3 (da) 2011-05-24 2021-05-10 Takeda As Oprullet kollagenbærer
ES2724233T3 (es) 2012-05-24 2019-09-09 Takeda As Aparato y proceso para proporcionar un portador de colágeno enrollado
PL2854737T3 (pl) 2012-05-24 2017-04-28 Takeda As Opakowanie
GB2543307B (en) * 2015-10-14 2020-12-09 Selentus Science Ltd Haemostatic device
WO2018051205A1 (es) * 2016-09-16 2018-03-22 Universidad De Los Andes Tapón hemostático de matriz extracelular para biopsias percutáneas y aparato para su fabricación
MD1169Z (ro) * 2016-12-06 2018-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de obţinere a spongiei de colagen
CN115869468A (zh) * 2018-12-28 2023-03-31 黄玲惠 生物支架和用于制备其的方法
DE102019213178A1 (de) * 2019-08-30 2021-03-04 Resorba Medical Gmbh Polymerfolie und Polymertasche zur Aufnahme eines zu implantierenden medizinisch-technischen Produkts
CN111839637B (zh) * 2020-09-04 2022-05-10 青岛市市北区蓝天心理研究所 一种妇科伤口缝合辅助装置
WO2022097149A1 (en) * 2020-11-05 2022-05-12 Datum Biotech Ltd. Multi-layered collagen structure

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021383A1 (en) * 1995-12-13 1997-06-19 Nycomed Arzneimittel Gmbh An instrument for the application of surgical material
WO2002058750A2 (en) * 2001-01-25 2002-08-01 Nycomed Pharma As A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
EP2052746A2 (en) * 2004-10-20 2009-04-29 Ethicon, Inc. Method for making an absorbable hemostat

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE404337A (ro) 1933-02-11 1900-01-01
GB423017A (en) 1934-05-24 1935-01-23 Koninklijke Pharma Fab Nv A process and apparatus for the manufacture of threads, strings, bands, films and the like from animal fibres
GB487258A (en) 1936-02-07 1938-06-17 Koninklijke Pharma Fab Nv Tampons and other porous articles, such as sheaths and bandages, and a process for producing same
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
US5147387A (en) 1990-10-10 1992-09-15 W. L. Gore & Associates, Inc. Process of implanting a prosthetic sheet repair material
US5290310A (en) 1991-10-30 1994-03-01 Howmedica, Inc. Hemostatic implant introducer
RU2018540C1 (ru) 1992-11-23 1994-08-30 Товарищество с ограниченной ответственностью Фирма "Копримекс" Способ получения коллагенсодержащего материала
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
US6177126B1 (en) 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
US5942278A (en) 1993-03-31 1999-08-24 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
AT402683B (de) 1995-05-16 1997-07-25 Hafslund Nycomed Pharma Gerät für endoskopische oder laparoskopische applikation von chirurgischem material
DE19546435A1 (de) 1995-12-13 1997-06-19 Nycomed Arzneimittel Gmbh Vorrichtung zum Einbringen von wundheilendem oder wundversiegelnden Material in den Körper
RU2118176C1 (ru) 1996-09-27 1998-08-27 Истранов Леонид Прокофьевич Способ получения коллагеновых пластинок
WO1998041154A1 (en) 1997-03-20 1998-09-24 Focal, Inc. Biodegradable tissue retractor
FR2777284B1 (fr) * 1998-04-10 2000-05-26 Hamza Mansour Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
DE19922078A1 (de) 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
US20020164322A1 (en) 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
CN1511014A (zh) 2001-04-13 2004-07-07 用于医疗的无菌箱
AU2002326451B2 (en) 2001-07-26 2008-04-17 Cook Biotech Incorporated Vessel closure member and delivery apparatus
US8465516B2 (en) * 2001-07-26 2013-06-18 Oregon Health Science University Bodily lumen closure apparatus and method
TWI324524B (en) * 2002-01-25 2010-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US6998510B2 (en) 2002-02-04 2006-02-14 Damage Control Surgical Technologies, Inc. Method and apparatus for improved hemostasis and damage control operations
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
JP4581318B2 (ja) 2002-08-09 2010-11-17 ニプロ株式会社 生分解性筒状体およびそれを用いた生体組織または器官再生器具
JP4168740B2 (ja) 2002-12-12 2008-10-22 ニプロ株式会社 コラーゲン製人工血管
US7329792B2 (en) 2003-02-04 2008-02-12 Damage Control Surgical Technologies, Inc. Method and apparatus for hemostasis
RU2235539C1 (ru) 2003-04-25 2004-09-10 Филатов Владимир Николаевич Способ получения порошкообразного материала для остановки кровотечений
CN1251655C (zh) * 2003-06-13 2006-04-19 常春荣 快速生物封闭止血装置及其制造工艺
US20050208095A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
CN2705167Y (zh) * 2004-02-20 2005-06-22 佟刚 胶原贴敷料
WO2005123171A2 (en) * 2004-06-09 2005-12-29 Stout Medical Group Lp Three-dimensional coils for treatment of vascular aneurysms
GB0415080D0 (en) 2004-07-05 2004-08-04 Ucl Biomedica Plc Methods for preparing tissue equivalent implants and products thereof
CN102389323B (zh) 2005-04-29 2015-11-25 库克生物科技公司 治疗瘘的立体移植物和相关方法与系统
JP4765602B2 (ja) 2005-12-14 2011-09-07 ニプロ株式会社 再生医療用器具の包装体及び再生医療用器具用の処理方法
US8795709B2 (en) 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
WO2008019129A2 (en) * 2006-08-04 2008-02-14 Stb Lifesaving Technologies, Inc. Solid dressing for treating wounded tissue
US8299316B2 (en) * 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
KR101541702B1 (ko) 2008-03-03 2015-08-04 옴릭스 바이오파머슈티컬스 리미티드 활성 성분을 포함하는 젤라틴 스펀지, 이의 제조 방법 및 용도
EP2276879B1 (en) 2008-04-11 2015-11-25 Virginia Commonwealth University Electrospun dextran fibers and devices formed therefrom
CN102076366B (zh) 2008-04-30 2014-06-11 伊西康公司 组织工程血管
KR101548766B1 (ko) 2008-05-02 2015-08-31 프로비던스 헬스 앤드 서비시즈, 오레곤 상처 드레싱 기구 및 방법
JP5157689B2 (ja) * 2008-07-07 2013-03-06 ニプロ株式会社 内視鏡下手術用デバイス
US9061464B2 (en) 2008-09-03 2015-06-23 Collagen Matrix, Inc. Re-rollable wrapping implant
WO2010053737A1 (en) 2008-10-29 2010-05-14 Wilson-Cook Medical, Inc. Endoscopic sheet delivery
CN201342005Y (zh) * 2009-02-02 2009-11-11 沂南县天成生物制品有限公司 一种壳聚糖复合生物止血膜
US8926552B2 (en) 2009-08-12 2015-01-06 Medtronic, Inc. Particle delivery
DK3243489T3 (da) 2011-05-24 2021-05-10 Takeda As Oprullet kollagenbærer

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021383A1 (en) * 1995-12-13 1997-06-19 Nycomed Arzneimittel Gmbh An instrument for the application of surgical material
WO2002058750A2 (en) * 2001-01-25 2002-08-01 Nycomed Pharma As A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
WO2002058749A2 (en) * 2001-01-25 2002-08-01 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
WO2002070594A2 (en) * 2001-01-25 2002-09-12 Nycomed Pharma As A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
EP1343542A2 (en) * 2001-01-25 2003-09-17 Nycomed Pharma AS Carrier with solid fibrinogen and solid thrombin
EP1359947A2 (en) * 2001-01-25 2003-11-12 Nycomed Pharma AS A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
EP1368419A2 (en) * 2001-01-25 2003-12-10 Nycomed Pharma AS A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
EP1547626A2 (en) * 2001-01-25 2005-06-29 Nycomed Pharma AS Carrier with solid fibrinogen and solid thrombin
EP2052746A2 (en) * 2004-10-20 2009-04-29 Ethicon, Inc. Method for making an absorbable hemostat

Also Published As

Publication number Publication date
EP3243489B8 (en) 2022-03-23
IL229446A (en) 2017-06-29
ES2642151T9 (es) 2018-01-08
AR086557A1 (es) 2014-01-08
EP3243489B1 (en) 2021-02-17
ME02830B (me) 2018-01-20
DK3243489T3 (da) 2021-05-10
MY185054A (en) 2021-04-30
TWI552774B (zh) 2016-10-11
CA2837117C (en) 2017-08-29
CO6862131A2 (es) 2014-02-10
JP6025824B2 (ja) 2016-11-16
CN103702645A (zh) 2014-04-02
DK2713972T3 (en) 2017-10-09
HUE032689T2 (en) 2017-10-30
RS56367B1 (sr) 2017-12-29
SA112330549B1 (ar) 2016-03-02
AU2012261339A1 (en) 2013-03-07
AU2012261339B2 (en) 2014-06-12
MX2013013435A (es) 2014-07-09
BR112013029709B1 (pt) 2021-07-20
US20180085322A1 (en) 2018-03-29
ZA201307060B (en) 2014-05-28
EA028878B1 (ru) 2018-01-31
MX355925B (es) 2018-05-04
HUE032689T4 (en) 2017-11-28
PL3243489T3 (pl) 2021-11-02
ES2642151T3 (es) 2017-11-15
LT2713972T (lt) 2017-09-11
WO2012159635A1 (en) 2012-11-29
HRP20171424T1 (hr) 2017-11-03
TW201300143A (zh) 2013-01-01
CY1119313T1 (el) 2018-02-14
PE20141037A1 (es) 2014-08-27
EA201391716A1 (ru) 2014-03-31
MD4471B1 (ro) 2017-03-31
EP3243489A1 (en) 2017-11-15
IL229446A0 (en) 2014-01-30
KR101833035B1 (ko) 2018-02-27
CL2013003274A1 (es) 2014-06-20
GEP201706715B (en) 2017-08-10
KR20140033425A (ko) 2014-03-18
UY34096A (es) 2018-06-29
EP2713972B9 (en) 2017-11-15
EP2713972A1 (en) 2014-04-09
US10532032B2 (en) 2020-01-14
US9814686B2 (en) 2017-11-14
SI2713972T1 (sl) 2017-10-30
MD20130097A2 (ro) 2014-06-30
AP2013007327A0 (en) 2013-12-31
TN2013000391A1 (en) 2015-01-20
CN103702645B (zh) 2015-10-21
EP2713972B1 (en) 2017-06-28
PL2713972T3 (pl) 2017-11-30
US20140072612A1 (en) 2014-03-13
ES2871064T3 (es) 2021-10-28
NZ615820A (en) 2015-10-30
JP2014519897A (ja) 2014-08-21
BR112013029709A2 (pt) 2020-12-15
CA2837117A1 (en) 2012-11-29
UA113959C2 (xx) 2017-04-10
PT2713972T (pt) 2017-09-22

Similar Documents

Publication Publication Date Title
MD4471B1 (ro) Purtător de colagen răsucit
HK1252027A1 (zh) 創傷敷料、用於製造創傷敷料的方法和設備以及其儲存和用途
WO2014067986A8 (en) Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
CO6680670A2 (es) Agonistas de ep4 prostaglandina útiles en la preparación de lal piel y la cicatrización de heridas
JP2014519897A5 (ro)
WO2012178089A9 (en) Trimmed-end aneurysm embolization devices
WO2010086863A3 (en) Crystalline drug-containing coatings
MX2013007919A (es) Dispositivos y metodos para tratamiento de heridas o de la piel.
MX2013004491A (es) Boronatos como inhibidores de arginasa.
PL2707014T3 (pl) Dimeryczne inhibitory PSD-95 o wysokim powinowactwie i ich zastosowanie w terapii niedokrwiennego uszkodzenia mózgu oraz leczeniu bólu
WO2012052873A3 (en) An apparatus for treating a product
WO2012071369A3 (en) A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
WO2012071516A3 (en) Devices and methods for the diagnosis and treatment of wounds using biomarkers
WO2012075174A3 (en) Compounds and methods for skin repair
CA2863809A1 (en) Prophylactic or therapeutic agent for idiopathic inflammatory myopathies
WO2014009488A3 (fr) Pansement a liberation prolongee d'actifs
WO2013059233A3 (en) Thermoresponsive compositions for dermatological use and methods thereof
WO2013117503A3 (en) Pi3k inhibitors for treating fibrotic diseases
WO2014020133A3 (en) Process and device
WO2019099860A3 (en) Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis
MY166065A (en) Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases
WO2011092564A3 (en) Process for the preparation of temsirolimus and its intermediates
GB0901540D0 (en) Apparatus,method and composition for topical treatment of warts and corns
UA54173U (ru) Способ асептизации раневых поверхностей у ж

Legal Events

Date Code Title Description
HC9A Name of applicant changed (patent for invention)

Owner name: TAKEDA AS, NO STR. DRAMMENSVEIEN 852, N-1383 ASKER

Free format text: PREVIOUS NAME OF APPLICANT: TAKEDA NYCOMED AS, NO STR. DRAMMENSVEIEN 852, N-1372 ASKER, NORVEGIA

FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees